Dnaprint Genomics Stock Alpha and Beta Analysis
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DNAPrint Genomics. It also helps investors analyze the systematic and unsystematic risks associated with investing in DNAPrint Genomics over a specified time horizon. Remember, high DNAPrint Genomics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DNAPrint Genomics' market risk premium analysis include:
Beta 0.0 | Alpha 0.0 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out DNAPrint Genomics Backtesting, DNAPrint Genomics Valuation, DNAPrint Genomics Correlation, DNAPrint Genomics Hype Analysis, DNAPrint Genomics Volatility, DNAPrint Genomics History and analyze DNAPrint Genomics Performance. DNAPrint Genomics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DNAPrint Genomics market risk premium is the additional return an investor will receive from holding DNAPrint Genomics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DNAPrint Genomics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DNAPrint Genomics' performance over market.| α | 0.00 | β | 0.00 |
DNAPrint Genomics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of DNAPrint Genomics' Buy-and-hold return. Our buy-and-hold chart shows how DNAPrint Genomics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.DNAPrint Genomics Market Price Analysis
Market price analysis indicators help investors to evaluate how DNAPrint Genomics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading DNAPrint Genomics shares will generate the highest return on investment. By understating and applying DNAPrint Genomics stock market price indicators, traders can identify DNAPrint Genomics position entry and exit signals to maximize returns.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Parabolic SAR | ||
| MidPoint over period | ||
| Stalled Pattern | ||
| Separating Lines |
DNAPrint Genomics Return and Market Media
Price Growth (%) |
| Timeline |
About DNAPrint Genomics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DNAPrint or other stocks. Alpha measures the amount that position in DNAPrint Genomics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2010 | 2011 | 2025 (projected) | Payables Turnover | 0.0317 | 0.56 | 0.5 | Days Of Inventory On Hand | 46.91 | 20.96 | 24.11 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards DNAPrint Genomics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, DNAPrint Genomics' short interest history, or implied volatility extrapolated from DNAPrint Genomics options trading.
Build Portfolio with DNAPrint Genomics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out DNAPrint Genomics Backtesting, DNAPrint Genomics Valuation, DNAPrint Genomics Correlation, DNAPrint Genomics Hype Analysis, DNAPrint Genomics Volatility, DNAPrint Genomics History and analyze DNAPrint Genomics Performance. For more detail on how to invest in DNAPrint Stock please use our How to Invest in DNAPrint Genomics guide.You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
DNAPrint Genomics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.